The Comparison of Oxidative Stress Between Inhalation Anesthetics
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00965445 |
|
Recruitment Status :
Completed
First Posted : August 25, 2009
Last Update Posted : August 26, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Oxidative Stress Cardiac Surgery |
Enhanced production of oxygen free radicals can lead to the generation of oxidative stress, which is harmful to human tissue and organs. Reactive oxygen species are released abruptly during some surgical procedures, and they are the major causes of ischemia-reperfusion injuries.Isoprostanes have been demonstrated to be a reliable biomarker for the evaluation of oxidative stress in vivo. Therefore, accurately monitoring and avoiding the occurrence of oxidative stress during surgery is an important clinical issue.
Isoprostanes are a series of prostaglandin-like compounds produced by non-enzymatic peroxidation of arachidonic acid.The aims of this study are(1)to develop an accurate liquid chromatography-tandem mass spectrometry methods for the detection of urinary isoprostane isomers in samples collected from patients receiving a cardiac surgery (2)to investigate the change of isoprostanes after cardiopulmonary bypass (3)to investigate the effect of different anesthetics on isoprostanes during surgery.
| Study Type : | Observational |
| Actual Enrollment : | 60 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Prospective |
| Official Title: | The Comparison of Oxidative Stress Between Inhalation Anesthetics |
| Study Start Date : | March 2007 |
| Actual Primary Completion Date : | December 2007 |
| Actual Study Completion Date : | December 2007 |
| Group/Cohort |
|---|
| cardiac surgery with CPB |
- isoprostanes isomer as marker of oxidative stress [ Time Frame: one day ]
Biospecimen Retention: Samples Without DNA
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 25 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- patients receiving cardiac valve surgery in ASA II-III physical status
Exclusion Criteria:
- trauma, infection, low ejection fraction (less than 25%), liver cirrhosis, or acute renal failure, and emergency surgery
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00965445
| Taiwan | |
| Dept. of Anesthesiology, Chang Gung Memorial Hospital | |
| Taipei, Taiwan, 105 | |
| Principal Investigator: | Yun-Hui Teng, MD | Chang Gung Memorial Hospital |
| Responsible Party: | Chang Gung Memorial Hospital |
| ClinicalTrials.gov Identifier: | NCT00965445 |
| Other Study ID Numbers: |
CGMH-IRB-96-0019B CGMH-IRB-96-0019B |
| First Posted: | August 25, 2009 Key Record Dates |
| Last Update Posted: | August 26, 2009 |
| Last Verified: | August 2009 |
|
isoprostanes mass spectrometry |
|
Respiratory Aspiration Respiration Disorders Respiratory Tract Diseases Pathologic Processes |

